tiprankstipranks
Scpharmaceuticals (SCPH)
:SCPH
US Market

scPharmaceuticals (SCPH) Income Statement

Compare
488 Followers

scPharmaceuticals Income Statement

Last quarter (Q3 2024), scPharmaceuticals's total revenue was $10.03M, an increase of 164.12% from the same quarter last year. In Q3, scPharmaceuticals's net income was $-35.10M. See scPharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 13.59M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 9.78M$ -468.00K$ -438.00K$ -399.00K$ -364.00K
Operating Expenses
$ 65.18M$ 36.16M$ 25.82M$ 29.93M$ 32.91M
Depreciation and Amortization
$ 626.00K$ 468.00K$ 438.00K$ 399.00K$ 364.00K
EBITDA
$ -46.06M$ -33.07M$ -25.02M$ -29.22M$ -30.86M
Operating Income
$ -55.40M$ -36.16M$ -25.82M$ -29.93M$ -32.91M
Other Income/Expenses
$ 586.00K$ -681.00K$ -2.21M$ -2.28M$ -91.00K
Pretax Income
$ -54.81M$ -36.84M$ -28.03M$ -32.21M$ -33.00M
Net Income
$ -54.81M$ -37.52M$ -30.49M$ -34.39M$ -34.41M
Per Share Metrics
Basic EPS
$ -1.42$ -1.32$ -1.11$ -1.40$ -1.85
Diluted EPS
$ -1.42$ -1.32$ -1.11$ -1.40$ -1.85
Weighted Average Shares Outstanding
38.51M 28.36M 27.35M 24.57M 18.60M
Weighted Average Shares Outstanding (Diluted)
38.51M 28.36M 27.35M 24.57M 18.60M
Currency in USD

scPharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis